| Document Date: 2015-03-20 10:30:37
Open Document File Size: 1.022,06 KBShare Result on Facebook
City Gender / / Company AMP / Ames / Novo Nordisk Inc. / / Country United States / / Currency pence / / Event Product Issues / FDA Phase / Product Recall / / Facility Laboratory Tests Bilirubin In / Laboratory Tests *Sections / / IndustryTerm neck imaging / injection site / healthcare / food consumption / oral contraceptive combination product / mL solution / colorless solution / peptide pharmaceuticals / / MedicalCondition neoplasms / severe vomiting / Adverse Reaction Nausea Diarrhea Vomiting Headache Constipation / liraglutide-induced rodent thyroid C-cell tumors / cholelithiasis / headache / thyroid disease / Adverse Reaction Nausea / dyspnea / persistent hoarseness / C-cell adenomas / thyroid C-cell tumors / chronic renal failure / primarily nonserious upper respiratory tract infections / alcohol abuse / MEN 2 / nausea / Malignant thyroid C-cell carcinomas / Thyroid C-cell carcinomas / severe nausea / injection site rash / Treatment-related malignant C-cell carcinomas / diabetic ketoacidosis / renal disease / chronic pancreatitis / diarrhea / Hypersensitivity / anaphylactic reactions / end-stage renal disease / constipation / hypoglycemia / pruritus / infections / medullary thyroid carcinoma / Serious Hypoglycemia / rodent C-cell tumor / papillary thyroid carcinoma / Gastroparesis / necrosis / thyroid nodules / adenomas / pre−existing gastroparesis / dose-dependent and treatment-duration-dependent thyroid C-cell tumors / cancer / fibrosarcomas / umbilical hernia / neoplasm / papillary thyroid carcinomas / dysphagia / Carcinogenesis / rodent thyroid C-cell tumors / thyroid tumors / diabetes / erythema / serious hypersensitivity / benign thyroid C-cell adenomas / vomiting / thyroid carcinoma / diabetes mellitus / specific infections / urticaria / angioedema / Multiple Endocrine Neoplasia syndrome type / Pancreatitis / Allergic reactions / OF THYROID C−CELL TUMORS / carcinomas / Renal Failure / acute pancreatitis / persistent severe abdominal pain / Cause Hypoglycemia / rash / acute renal failure / prior serious hypersensitivity / e.g. urticaria / dehydration / / MedicalTreatment Oral Contraceptives / counseling / hemodialysis / dialysis / / Organization US Federal Reserve / DOSAGE AND ADMINISTRATION / FDA / / Person Ser Phe Ile Ala Trp / Ser Glu Ala Ala Gln / Ser Asp Lys Glu Val / / / Position Counsel / Major / / Product Injection site reactions Injection / Acetaminophen / Victoza®-treated patients / glucagon / glimepiride / The injection / mg / levonorgestrel / FDA-Approved Medication / Lisinopril / Digoxin / Griseofulvin / rosiglitazone / glycemic control / Victoza / Victoza® / sitagliptin / / Technology antibodies / ultrasound / Pharmacokinetics / Pharmacodynamics / recombinant DNA / dialysis / / URL www.fda.gov/medwatch / /
SocialTag |
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Victoza® safely and effectively. See full prescribing information for Victoza®. Victoza® (liraglutide [rDNA origi